- Embolic Coils
- Flow Diversion Device
- Liquid Embolic Agents
- Hospitals
- Ambulatory Surgical Units
- Clinics
- Market Forecast for 2024-2030
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End user/application Analysis
Aneurysm Coiling & Embolization Devices Market Report Analysis & Forecast 2024-2030
Aneurysm Coiling and Embolization Devices Market by Product Type ( Embolic Coils, Flow Diversion Device, Liquid Embolic Agents) by Application / End User ( Hospitals, Ambulatory Surgical Units, Clinics ) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)
Global Aneurysm Coiling & Embolization Devices Market Report is expected to reach USD 4805.41 million by 2031 with CAGR of 9.1 % between 2025 and 2031
In Aneurysm Coiling & Embolization Devices, the endovascular coiling separates an aneurysm from getting entangled with the usual movement without blocking any small arteries close to the main vessel. The endovascular coiling proves to be a slightly offensive technique of opening the aneurysm from within the bloodstream, particularly during angiography. The Aneurysm Coiling & Embolization Devices are the ones in which the Embolization Device (PED) is specified for the endovascular action of adults (22 years of age or grown-ups) with giant wide-necked intracranial aneurysms (lAs) in the inner carotid vein from the petrous to the larger hypophyseal sections.
North America accounts for the largest industry share at present and is likely to hold its top position over the forecast period. The key factors driving the growth of North American market comprise of favorable reimbursement structure, especially in the U.S., availability of R&D investments, and increasing adoption of neurovascular devices by neurosurgeons due to the technological sophistication. In addition, the Asia Pacific region will exhibit the highest growth. The major revenue contributor in this region is Japan, accounting for nearly 43% of the market share, and it will retain its top position during the forecast period. The growth can be attributed to technological advancements in the region. Other major markets are China and India.
Global Aneurysm Coiling & Embolization Devices Market: Product Type
Global Aneurysm Coiling & Embolization Devices Market: End Users/Application Analysis
Global Aneurysm Coiling & Embolization Devices Market Report Report delivers a comprehensive analysis of the following parameters:
Report Coverage
| Parameters | Details |
|---|---|
Base Year |
2024 |
Historical Data |
2018-2023 |
Forecast Data |
2024-2030 |
Base Year Value (2024) |
USD 2194.36 million |
Forecast Value (2031) |
USD 4805.41 million |
CAGR (2025-2030) |
9.1 % |
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Frequently Asked Questions (FAQ)
Aneurysm Coiling & Embolization Devices Market Report was valued at around USD 2194.36 million in 2023 & estimated to reach USD 4805.41 million by 2030.
Aneurysm Coiling & Embolization Devices Market Report is likely to grow at Compound Annual Growth Rate (CAGR) of 9.1% between 2024 to 2030.
North America accounts for the largest industry share in Aneurysm Coiling & Embolization Devices Market.
Some of the top companies included in the research report are Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc., Stryker, TERUMO CORPORATION,,,,,.
The growth of the Aneurysm Coiling & Embolization Devices Market can be attributed to technological advancements.
Yes, the report includes COVID 19 impact on the market.
We are committed to offering 100 % free customization while purchasing.